DE69932733D1 - Photosensitizer-konjugate zur zielrichtung von intrazellulare pathogene - Google Patents

Photosensitizer-konjugate zur zielrichtung von intrazellulare pathogene

Info

Publication number
DE69932733D1
DE69932733D1 DE69932733T DE69932733T DE69932733D1 DE 69932733 D1 DE69932733 D1 DE 69932733D1 DE 69932733 T DE69932733 T DE 69932733T DE 69932733 T DE69932733 T DE 69932733T DE 69932733 D1 DE69932733 D1 DE 69932733D1
Authority
DE
Germany
Prior art keywords
targeting
pathogenes
intra
cellular
intracellular pathogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69932733T
Other languages
English (en)
Other versions
DE69932733T2 (de
Inventor
Tayyaba Hasan
Jerome Gross
J Nau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of DE69932733D1 publication Critical patent/DE69932733D1/de
Application granted granted Critical
Publication of DE69932733T2 publication Critical patent/DE69932733T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
DE69932733T 1998-10-16 1999-10-15 Photosensitizer-konjugate zur zielrichtung von intrazellulare pathogene Expired - Lifetime DE69932733T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10458498P 1998-10-16 1998-10-16
US104584P 1998-10-16
US11597699P 1999-01-15 1999-01-15
US115976P 1999-01-15
PCT/US1999/024124 WO2000023117A1 (en) 1998-10-16 1999-10-15 Photosensitizer conjugates for targeting intracellular pathogens

Publications (2)

Publication Number Publication Date
DE69932733D1 true DE69932733D1 (de) 2006-09-21
DE69932733T2 DE69932733T2 (de) 2007-08-16

Family

ID=26801704

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69932733T Expired - Lifetime DE69932733T2 (de) 1998-10-16 1999-10-15 Photosensitizer-konjugate zur zielrichtung von intrazellulare pathogene

Country Status (7)

Country Link
US (2) US6610298B2 (de)
EP (1) EP1133319B1 (de)
JP (1) JP2002527494A (de)
AT (1) ATE335513T1 (de)
CA (1) CA2347045A1 (de)
DE (1) DE69932733T2 (de)
WO (1) WO2000023117A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137901A1 (en) * 2001-01-22 2002-09-26 Cavanaugh Philip Gerard Synthesis, and photodynamic therapy-mediated anti-cancer, and other uses of chlorin e6-transferrin
US8703146B2 (en) * 2001-04-20 2014-04-22 Institute For Systems Biology Toll-like receptor 5 ligands and methods of use
WO2002085933A1 (en) * 2001-04-20 2002-10-31 The Institute For Systems Biology Toll-like receptor 5 ligands and methods of use
US20040116350A1 (en) * 2001-09-17 2004-06-17 Paul Wentworth Jr Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
US20030176326A1 (en) * 2002-03-15 2003-09-18 Ceramoptec Industries Inc. Photosensitzers for photodynamic therapy of microbial infections
US20050163821A1 (en) * 2002-08-02 2005-07-28 Hsing-Wen Sung Drug-eluting Biodegradable Stent and Delivery Means
CN104587479A (zh) 2002-12-09 2015-05-06 阿布拉西斯生物科学有限责任公司 组合物和传递药剂的方法
WO2004052401A2 (en) * 2002-12-09 2004-06-24 American Bioscience, Inc. Compositions and methods of delivery of pharmacological agents
CA2530166A1 (en) * 2003-03-07 2004-09-23 Randolph D. Glickman Antibody-targeted photodynamic therapy
WO2007038201A1 (en) * 2005-09-23 2007-04-05 Bioenvision, Inc. Methylene blue therapy of parasitic infections
US8999933B2 (en) * 2006-01-18 2015-04-07 Biolitec Pharma Marketing Ltd Photodynamic cosmetic procedure and healing method
US20090030257A1 (en) * 2007-07-25 2009-01-29 Ceramoptec Industries Inc. Anti-microbial photodynamic therapy
WO2008098100A2 (en) * 2007-02-07 2008-08-14 Perscitus Biosciences, Llc Detection of molecule proximity
US8633311B2 (en) 2008-07-29 2014-01-21 Frontier Scientific, Inc. Topical application of porphyrins for killing or preventing the growth of bacteria or fungi on a mammal
US8859760B2 (en) 2008-07-29 2014-10-14 Frontier Scientific, Inc. Compositions for killing or preventing the growth of microbes
KR101265525B1 (ko) * 2010-11-12 2013-05-21 서울대학교병원 (분사무소) 광역학적 치료를 통한 결핵균 활성 억제 방법
US8668727B2 (en) 2011-08-23 2014-03-11 Anthony Natale Systems and methods for treating pathogenic infection
US9023092B2 (en) 2011-08-23 2015-05-05 Anthony Natale Endoscopes enhanced with pathogenic treatment
ES2627026T3 (es) * 2011-09-05 2017-07-26 Hiroshi Maeda Sonda molecular fluorescente de tipo polímero
WO2017019836A1 (en) 2015-07-28 2017-02-02 Photonmd, Llc Systems and methods for phototherapeutic modulation of nitric oxide
US20210128935A1 (en) 2015-07-28 2021-05-06 Know Bio, Llc Phototherapeutic light for treatment of pathogens
GB201718631D0 (en) * 2017-11-10 2017-12-27 Pci Biotech As Method
US11147984B2 (en) 2020-03-19 2021-10-19 Know Bio, Llc Illumination devices for inducing biological effects
US12011611B2 (en) 2020-03-19 2024-06-18 Know Bio, Llc Illumination devices for inducing biological effects
US11986666B2 (en) 2020-03-19 2024-05-21 Know Bio, Llc Illumination devices for inducing biological effects
US11654294B2 (en) 2021-03-15 2023-05-23 Know Bio, Llc Intranasal illumination devices
EP4422686A1 (de) 2021-10-26 2024-09-04 Grant Demartino Industries LLC Magnetostriktive piezoelektrische nanoanordnung als chemotherapeutikum gegen krebs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177073A (en) * 1988-09-30 1993-01-05 Baylor Research Institute Therapeutic compositions derived from photoactive compounds
US5091385A (en) 1988-09-30 1992-02-25 Baylor Research Institute Pre-activated therapeutic agents derived from photoactive compounds
US5332567A (en) * 1989-08-24 1994-07-26 Immunomedics Detection and treatment of infections with immunoconjugates
CA2047969A1 (en) 1990-08-17 1992-02-18 Thomas D. Madden Benzoporphyrin vesicles
US5405957A (en) 1992-10-30 1995-04-11 The University Of British Columbia Wavelength-specific photosensitive compounds and expanded porphyrin-like compounds and methods of use
DE19514087A1 (de) * 1995-04-13 1996-10-17 Deutsches Krebsforsch Konjugat aus einem Wirkstoff, einem Polyether und ggfs. einem nicht als körperfremd angesehenen, nativen Protein

Also Published As

Publication number Publication date
US6977075B2 (en) 2005-12-20
CA2347045A1 (en) 2000-04-27
EP1133319A4 (de) 2002-04-03
JP2002527494A (ja) 2002-08-27
US20020122805A1 (en) 2002-09-05
US6610298B2 (en) 2003-08-26
US20030224002A1 (en) 2003-12-04
DE69932733T2 (de) 2007-08-16
EP1133319A1 (de) 2001-09-19
EP1133319B1 (de) 2006-08-09
ATE335513T1 (de) 2006-09-15
WO2000023117A1 (en) 2000-04-27

Similar Documents

Publication Publication Date Title
DE69932733D1 (de) Photosensitizer-konjugate zur zielrichtung von intrazellulare pathogene
CY1118363T1 (el) Αντισωματα που ανοσοειδικως συνδεονται προς blys
CY1105389T1 (el) Hpv-e7 ως αγωγη εναντι του ιου θηλωματων ανθρωπου
CY1118334T1 (el) Χρηση δαπτομυκινης
CY1106283T1 (el) Κινολινυλ-πυρρολοπυραζολες
BR0112104A (pt) Processos para tratamento de doenças reumáticas usando uma molécula de ctla4 solúvel
ES2114051T3 (es) Quelantes a base de poliamina modificada por carboxamida y complejos radiactivos y conjugados.
CY1111613T1 (el) Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv
ECSP034855A (es) Administracion pulmonar de insulina quimicamente modificada
BR0210568A (pt) Conjugado, uso de um conjugado, composição farmacêutica, e, método para tratar câncer em um mamìfero
CY1107615T1 (el) Θεραπευτικοι συνδυασμοι αντιυπερτασικων και αντιαγγειογενετικων παραγοντων
AR027355A1 (es) Acidos tiazolidincarboxilicos
YU77000A (sh) Primena peg-ifn-alfa i ribavirina za lečenje hroničnog hepatitisa c
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
ES2051641B1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
DE60134324D1 (de) NEUE HEILMITTEL FüR KREBS
AR032293A1 (es) Estuche farmaceutico
NO20032027L (no) Effektive antitumorbehandlinger
ATE402713T1 (de) Genetisch manipulierte herpesviren zur behandlung von tumoren
CY1105309T1 (el) Συμπλεγμα εμβολιου που προοριζεται για προληψη και θepαπεια των λεϊσμανιασεων
CY1106449T1 (el) Βελτιωμενη μεθοδος για εκριζωση του helicobacter pylori
PT1007055E (pt) Utilizacao de amifostina
EA200400214A1 (ru) Азитромицин в виде разовой дозы
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition